Efficacy and Safety of Tofacitinib in the Treatment of Refractory Chronic Spontaneous Urticaria: A Real-World Study

The set of supplemental materials support the JAAD manuscript “Efficacy and Safety of Tofacitinib in the Treatment of Refractory Chronic Spontaneous Urticaria: A Real-World Study” supplementary Table 1. Comparison of demographic characteristics between responders and non-responders to tofacitinib. supplementary Table 2. Comparison of laboratory findings between responders and non-responders to tofacitinib. supplementary Figure 1. ROC curve analvsis of BLR and Lymph for predicting response to tofacitinib in refractory CSU.